Ask Dr. Drew - New Study: Long COVID Symptoms & Spike Protein Detected Months After mRNA Vaccination w/ Ed Dowd & Dr. Kelly Victory – Ask Dr. Drew – Ep 344
Episode Date: April 9, 2024In a new preprint, researchers studied people who received mRNA vaccines and experienced Post-Acute Sequelae of COVID (PASC) also known as “Long COVID.” They discovered that the spike protein cont...inued to appear in the immune cells of post-vaccine patients long afterward – some for more than 245 days. “These cells bind to the blood vessels. They cause endotheliitis and vascular inflammation, which I think now has been corroborated by many as being probably one of the most important pathogenic mechanisms in long COVID,” Dr. Patterson, who was an author of the study, told The Epøch Times. Ed Dowd is founder of Phinance Technologies and author of “Cause Unknown: The Epidemic of Sudden Death in 2021 & 2022.” Dowd is a former Wall Street analyst and BlackRock portfolio manager who utilized pattern recognition to get ahead of his peers during his stock picking career. He is a founding partner of Phinance Technologies. Follow Dowd at https://x.com/DowdEdward Dr. Kelly Victory MD is a board-certified trauma and emergency specialist with over 30 years of clinical experience. She served as CMO for Whole Health Management, delivering on-site healthcare services for Fortune 500 companies. She holds a BS from Duke University and her MD from the University of North Carolina. Follow her at https://earlycovidcare.org and https://x.com/DrKellyVictory 「 SPONSORED BY 」 Find out more about the companies that make this show possible and get special discounts on amazing products at https://drdrew.com/sponsors • COZY EARTH - Susan and Drew love Cozy Earth's sheets & clothing made with super-soft viscose from bamboo! Use code DREW to save up to 40% at https://drdrew.com/cozy • TRU NIAGEN - For almost a decade, Dr. Drew has been taking a healthy-aging supplement called Tru Niagen, which uses a patented form of Nicotinamide Riboside to boost NAD levels. Use code DREW for 20% off at https://drdrew.com/truniagen • PET CLUB 24/7 - Give your pet's body the natural support it deserves! No fillers. No GMOs. No preservatives. Made in the USA. Save 15% at https://drdrew.com/petclub247 • GENUCEL - Using a proprietary base formulated by a pharmacist, Genucel has created skincare that can dramatically improve the appearance of facial redness and under-eye puffiness. Get an extra discount with promo code DREW at https://genucel.com/drew • PROVIA - Dreading premature hair thinning or hair loss? Provia uses a safe, natural ingredient (Procapil) to effectively target the three main causes of premature hair thinning and hair loss. Susan loves it! Get an extra discount at https://proviahair.com/drew • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your personal physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. 「 ABOUT DR. DREW 」 Dr. Drew is a board-certified physician with over 35 years of national radio, NYT bestselling books, and countless TV shows bearing his name. He's known for Celebrity Rehab (VH1), Teen Mom OG (MTV), The Masked Singer (FOX), multiple hit podcasts, and the iconic Loveline radio show. Dr. Drew Pinsky received his undergraduate degree from Amherst College and his M.D. from the University of Southern California, School of Medicine. Read more at https://drdrew.com/about Learn more about your ad choices. Visit megaphone.fm/adchoices
Transcript
Discussion (0)
Hey, well, there we are. Hi, and a little bit of excitement there. Nothing like an IT crash
right as you're starting the show. Welcome. Thanks for joining me. I'm Dr. Kelly Victory,
filling in for Dr. Drew, who's traveling today. I have a really great show with one of my favorite
people and our favorite guests, Ed Dowd, who I'm going to bring in sooner than later since we ate up a little bit of his time on the show dealing with some technical issues.
Thank you, Caleb, for getting it sorted out. we just marked the official four-year anniversary of the pandemic or the scandemic or the COVID
debacle, however you want to look at it. I think it was March 20th that was the official date of
the two weeks to flatten the curve lie. And in these last four years, an awful lot has happened. But just in the recent past,
last couple of weeks, we've had some monumental things that really have started, I think, to
perhaps turn the tide here. We've got the Missouri v. Biden case, now known as Murthy v. Biden,
which is the case against the federal government for censorship and the egregious
affront to free speech by colluding with big tech and the mainstream media to silence the voices of
quite a few Americans. And during this, it's now being heard by the Supreme Court. The Supreme
Court heard oral arguments this past week or the week before. Also this last week, we saw the FDA
forced to capitulate with regard to their disinformation campaign that they ran on
ivermectin during the COVID pandemic. They have been forced to take down all of the disinformation,
the social media posts and other postings
that they said with regard to the fact that,
you know, their claim that ivermectin didn't work
and was horse-paced and all of that other nonsense.
That was a great case brought by some real titans
in the medical world, including Pierre Corey,
another friend of this show,
and Drs. Merrick
and Mary Talley Bowden, who brought that case. So it was very quiet, but the FDA has been forced
to concede that fundamentally they lied. We're also seeing the reversal of vaccine mandates on
a lot of college campuses, university campuses, and that's all great.
All of that said, at the same time in the parallel universe, we're seeing concerns about avian flu
when you still keep hearing about disease X out there. And there's always the ever,
the crowd favorite booster, booster, booster that's being promulgated by the FDA and the pharmaceutical companies.
So there are two things happening at the same time. While people are opening their eyes,
I think, to the reality of what happened during the pandemic, there's still a lot to be afraid
of with regard to what's happening and the powers that be that are continuing to raise the fear flag. And that's one of the reasons
I was thrilled to have our guest, Dowd, who I'm going to bring on, as I said, after this break,
to really talk about the latest. Ed always shows up with the receipts. He always brings the goods.
So he has the data with regard to some interesting and somewhat concerning trends that we're seeing with regard
to disease processes and disability. And one of the things that I love about Ed is he's not here
to say necessarily what's causing it. He's just exposing the data and we can discuss some possible
ideas about what's causing it. You and I both know what we think it is. But let's cut to
the break so I don't eat up any more of his time and I'll come back and bring Ed with me after I
return. Thanks. Our laws as it pertained to substances are draconian and bizarre.
The psychopath started this. He was an alcoholic because of social media and pornography, PTSD, love addiction, fentanyl
and heroin.
Ridiculous.
I'm a doctor for.
Where the hell do you think I learned that?
I'm just saying, you go to treatment before you kill people.
I am a clinician.
I observe things about these chemicals.
Let's just deal with what's real.
We used to get these calls on Love Line all the time.
Educate adolescents and to prevent and to treat.
If you have trouble, you can't stop and you want help stopping, I can help. I got a lot to say. I got a lot more to say.
Let's talk about aging because everyone wants to know how to slow it down. For almost a decade,
I've been taking a healthy aging supplement
called TruNiagen.
This supplement boosts NAD.
That's something that cells can't live without.
It's done with a patented form of nicotinamide riboside
called NR or Niagen.
It's more efficient and more scientifically reviewed
than NMN or other NAD boosters.
TruNiagen is truly the best way to boost NAD levels. And it's made by Chromadex. They're the gold standard in the NAD boosters. TruNiogen is truly the best way to boost NAD levels.
And it's made by Chromadex.
They're the gold standard in the NAD space.
Dr. Charles Brenner, the scientist who discovered
the NAD boosting potential of NR, explains.
And the center of the metabolism that allows the conversion
of food into energy is NAD coenzymes.
And NAD gets disturbed in the aging process. And as we're
exposed to conditions of metabolic stress, Niagen, which is the form of NR that was developed by
Chromadex, is the best and the only fully legal form of NR. And this is really the gold standard for NAD boosting vitamins.
I love this product. I urge you to try it. Go to drdrew.com slash truniagen for 20% off your order.
That is drdrew.com slash truniagen, T-R-U-N-I-A-G-E-N, and enter drdrew at checkout,
D-R-D-R-E-W, enter it at the checkout for 20% off.
Thanks again for joining me.
And again, my apologies for our little IT glitch there
at the beginning and the subsequent delay.
I'm joined today by Ed Dowd,
who most of you know he's been on the show many times
and he's been a remarkable
researcher during this last four years of the COVID debacle. Ed Tech was a former
Wall Street guy. He is a BlackRock portfolio manager. He now has been the founder of
Finance Technologies, and importantly, the author of the book,
Cause Unknown, the Epidemic of Sudden Deaths in 2021 and 2022. He has exposed more data with regard to trends and alarming information about increases in disease processes and disabilities
throughout the pandemic. One of the things I think
that is interesting about him is that he's not a medical professional. He's not a physician. He's
not a scientist. He's somebody who made a living looking at trends in pattern recognition. That's
how he got ahead in Wall Street, by looking at patterns. And it was bringing that pattern recognition capability
and expertise to what was going on in COVID that brought him to where he is now. So I'm going to
bring Ed on. There's so much stuff I want to cover with him. He's got some new data to share with us,
as well as we're going to probably, if we have time, talk about a very new study, a preprint,
actually looking at some information about quote long COVID and perhaps the causes of long COVID
and whether it's actually a disease process in and of itself, or is actually a tangential or
offshoot of a vaccine injury. So let's bring Ed on here and we'll get into the details. Hey, Ed,
thanks for joining me. Sorry about the glitch. No problem. Great to be here. Where do you want
to start? Yeah, well, actually, before we get into the first kind of new data, take five minutes,
if you will, because I didn't do a very good job of explaining how you got into this.
Tell for the people who may not have heard you live before or really know of your background,
how it is that you went from a Wall Street black rock guy to somebody who knows anything about or
even vaguely invested in or interested in what is happening in a pandemic. What got you even interested in this
and sort of heightened your awareness
that something was awry?
Well, I'm a Wall Street executive,
formerly a growth portfolio manager at BlackRock,
and we analyze trends in company earnings
and revenues and growth projections.
And we also looked at the industry-wide data to get a handle on trends.
And you wanted to identify a trend, honestly, right around when the time it's changing
so that you can be the first one to the trend before anybody else sees it.
That's how you make the most money.
So my brain is wired to see trends.
And honestly, when the pandemic hit and there was the introduction and fanfare about a new novel on tested therapy,
I just had the inclination to pause personally and say, I'm not taking anything that hasn't been tested on humans,
done under Operation Warp Speed, and also knowing that it takes seven to 10 years for a vaccine to
be properly vetted. So I paused, and I live on Maui. And in my friend group, not one person I
knew got COVID. We heard of people getting COVID, but no one in my friend group in 2020 got COVID.
Then in 2021, people started getting COVID, and people started getting the vaccine. And I started
hearing about adverse reactions anecdotally, about people's uncles dying mysteriously on the mainland.
So, look, I'm a stats guy.
And I know if this thing was safe as they said it was, I anecdotally shouldn't be hearing anything.
The odds of me hearing something, you know, one case, one adverse event should be near impossible.
But I was hearing multiple.
So that just got my interest.
I had a thesis. Something was going got my interest. I had a thesis,
something was going wrong here. So it's a thesis at that point. And then as time rolled on,
the mandates came. And that's when I became politically activated and started protesting the mandates. Dr. Malone happened to come to Maui. I had a dinner with him and he suspected
there was issues with the vaccine as well.
And I said, look, if we're right, it'll start showing up in places where people might not suspect, like insurance company results, funeral home results.
And they did. And then as time went on, I, you know, people started helping me.
Josh Sterling was one of the first. He was a former Wall Street insurance sell side analyst.
We started looking at CDC data. He then went off to go do uh the coalition to save lives and then uh
around summer of 2022 uh i hooked up with two guys in finance uh carlos allegria and yuri
we founded a company called finance technologies and it's uh basically a two-fold company at this
point it's a and the first project was to figure out
what was going on with the metadata
in terms of excess deaths, disabilities, injuries,
started looking at causes.
So that was kind of like our pro bono work
that we did pre-revenue.
And we're in the process of trying to raise capital
right now for our hedge fund strategy,
which of course, you know, utilizes data
and market information and fundamental economic indicators. And now we have amassed two,
three years worth of this other kind of data. And it's something that is going to probably
turn into a business because our company was founded upon taking data, turning it into knowledge,
taking data, turning it into information, taking data, turning it into information,
information into knowledge, and then decision-making.
So what we've collected is a business.
And what we don't make publicly available is projections.
That's something people will pay for,
but we happily provide all the damage that's been done
since the countermeasures from the pandemic.
And you can point fingers at whatever you want,
but the bottom line scorecard is it's a disaster.
And whatever they did, it resulted in more excess deaths,
disabilities, and injuries, you know, in most of the Western nations.
Exactly.
And I want to get into that data.
I might make as an aside, by the way,
that pattern recognition and analysis of trends
used to be what we called back in the olden days, science.
That's what scientists used to do back when they had integrity and they would follow those
trends, look at that data and actually be interested, have some intellectual curiosity
to say, wow, what is causing that trend? One of the things that
you and I have talked about quite a bit offline, Ed, is why is it, and we can get into this later,
why is it that the powers that be, the organizations, specifically the CDC and others,
whose job it is to analyze these trends and to understand why we are having increases in certain disease processes
or disabilities. Why is it that they have been absolutely remiss? They're nowhere to be found.
Here we got a former BlackRock guy, Wall Street analyst, and a group of your friends and colleagues
who are diving into the scientific detail when the organizations who are empowered to do that
or really mandated to do that on behalf of the American people are empowered to do that or really mandated to do that
on behalf of the American people are nowhere to be found. I find that interesting. Before you
actually get into the most recent data, which I want to talk about, which includes some stuff about
cancer specifically and also disabilities, talk a little bit about your book too. Your book's been
out now for over a year, right? A Cause Unknown about the sudden deaths. Talk a little bit about your book, too. Your book's been out now for over a year, right?
A Cause Unknown About the Sudden Deaths.
Talk a little bit about that book and what you expose in the book.
Well, the book came out in December 2022.
And we're a year and a quarter into it, more data since the book.
So we've discovered way more than the book has in it right
now. But the biggest thing we found was there was a mix shift from old to young. In 2020,
there were about 500,000 excess deaths in the U.S., mostly old. And then mysteriously in 2021,
we saw a mix shift. And to put numbers to it, which I did in front of Senator Ron Johnson in February in a recent
Senate hearing. It wasn't an official hearing. It was a committee. But I was able to give the
scorecard. And there were about 124,000 deaths in the age group 16 through 64, which is the
working age group. And that was in 2020. That was the absolute number
of excess deaths. Then in 2021, it shot up to about 224,000 excess deaths, about a 75% increase.
And the same number of excess deaths occurred in 2020 and 2021, except that we just shifted around
who got hit hard. And so the old people died mostly in 2020,
and then the young accelerated in 2021.
And that's very curious.
If you talk to any virologists,
those numbers are just way out there.
You don't go from a virus that attacks the old
and goes after working-age population.
We also found that disabilities seem to go up for those who are employed the most.
So we added about 4 million new disabilities from the five-year, four-year trend before that, starting in February of 21, and half of them were employed.
So why did the employed get hit harder than the whole general U.S. population?
Their rate of change in disability rate was 38%.
The general U.S. population's rate of change in disability rate was 38%. The general U.S. population's rate
of change in disabilities was nine. So, you know, this is, you know, not exactly rocket science.
My thesis is the vaccine is the predominant cause of that phenomenon, that new novel. Now,
that's my opinion. And as time goes on and we do more work, it's becoming increasingly clear the
vaccine had a large part to do with what's going on today.
Oh, I think it's irrefutable.
And for those people who haven't connected the dots, I mean, yes, the reason it went
that those disabilities and deaths went up in the working age population is because that's
who was mandated to take the vaccines.
So there was a, they were largely vaccinated populations that had
the increases in these disabilities. So let's talk about, let's talk about the newest data that,
that you have crunched, if you will, with regard to, you know, start wherever you want to start.
We've got a couple of different charts I know that you provided, and I'm happy to, you know,
start where you'd like to start. And walk me
through it like I'm five years old, like I don't have any scientific background. So we understand
what these charts and what this data reveals. Yeah. So before we put up charts, let me give
you a little background. So we put out a paper last September on the UK in cancers in the same
age group we just are about to talk about in the US.
So it's 15 to 44. The problem we have with that data was it was incomplete. 2022 had a disconnect
between registered deaths and causes, about a 30% gap. So we made what we call adjusted numbers
using ratios. We think the methodology is sound. So we came up with rising, we showed rising cancers.
So what we wanted to do with this next paper was corroborate our findings in the UK, in the US.
The good news about the US is the data is provisional, but it's more complete. So we
don't have the adjusted number problem we had in the UK. So we put out two papers recently.
The first one I'm going to talk about is ages 15 to 44, same age group as the UK. So we put out two papers recently. The first one I'm going to talk about
is ages 15 to 44, same age group as the UK. And we had a contributor on this paper, Dr. David Wiseman,
who is a PhD epidemiologist. And we dropped it on ResearchGate as a preprint a couple of weeks ago.
And in chart one, I just want to show you in this age group what happened. We saw a slight rise in, this is underlying causes.
We looked at underlying causes and multiple causes, but this is just underlying cause,
just cancer as the primary cause of death.
And it went up 1.7% in 2020 with a Z score of three and a half.
So a slight signal.
So something happened in 2020 that needs to be investigated.
But it really accelerated in 2021, went up 5.6 percent in this age group, 11.8 percent, 11.8 standard deviation Z score, and then went up 7.9 percent in 2022, 16 and a half standard deviation.
So you can see there was a trend down of cancer in this age group.
And then it changed and starting slightly in 2020, a little bit above trend, then it took off in 21 and 22.
Let me interject here for one second just to put some sort of clinical color on this as well.
You know, cancer is largely a disease of the very young and the very old. There are certain cancers that attack the
young, primarily the leukemias, and attack viciously, unfortunately. And then cancers,
generally, we start to see increases in cancers in people after the age of 55 or 60. The age group
15 to 45 is not a group of people in which whom you normally see large
numbers of cancers anyway. So seeing this trend, I think you said a five plus percent increase
from 2021 to 2022 is massive in a group of people in whom you don't normally see a lot of cancers in the first place? It was 7.9 from 21 to 22 above trend.
It was 5.6 above trend in 21, 7.9% above trend in 2022 if the trend had continued.
So it's huge.
And the next chart just shows the Z scores for both multiple cause and underlying cause deaths.
And that's not that important.
It just shows that something changed.
And it started really in 2020 and really accelerated in 2021.
So in the paper, we cite what we speculate as to possible causes. We speculate as to COVID,
missed cancer screening treatments, which, you know, honestly doesn't really occur in this age
group. So we put it in there, we put it in the paper, we put in lockdowns, and we put in vaccines.
So we named all four as possible causes that need to be investigated, but vaccines need to be in
there. And I personally and the team thinks it's mostly the vaccines, but again, we're, we're, we're putting out a trend.
It's a real trend and I'm not going to get into the debate that it's not happening because it's
happening and we're going to sell this information and make money. So what all the trolls who want to
get into, it's not happening. Good luck to you. So this is, this is, this is what we're seeing.
It's a disturbing trend in this age group,
which shouldn't be happening like this. It's just, it's tragic.
Yeah. And the reason I brought up the issue about cancer being primarily a disease of the very young
and the older age group is specifically to rule out that issue of quote, miss cancer screenings.
15 to 44 isn't an age group. People
are not getting routine screening mammograms. They're not getting routine screening colonoscopies.
They're not even getting routine screening skin cancer exams in those age groups. So I don't
believe you can make a plausible argument that missing a screening exam during COVID, during the shutdown,
was why we're seeing this increase. Furthermore, while I can give you several very plausible
reasons why the vaccines could account for these increases in cancers, I have yet to hear a single
argument for how COVID itself, the virus itself could.
And that's why it's interesting to see this trend with cancer. When we were talking just about
things like blood clots, and people could make the argument that COVID, that the spike proteins
in COVID did cause clotting, and they do. So you could have had an increase in strokes or an
increase in heart attacks, blood clots to the lung, for example,
from COVID. But I cannot think of a single mechanism by which COVID, the virus, would be
causing an increase in cancers. So I personally am hard-pressed to come up with any other explanation
other than the vaccines.
And as I said, I can give you multiple possible mechanisms by which the vaccines would cause this.
But as you said, you're not even going there. You're saying, here's the data. This is happening.
It is more than a worrisome trend because I believe that we are seeing just the tip of the
iceberg. Do you see, you know, you're showing us two years' worth of data.
What's going on?
Are you seeing any evidence that this trend is, you know, starting to level out?
Is it plateauing?
Is it continuing on the rise?
We don't have the 2023 data that we've got yet.
But the good news is I do think disabilities have leveled out.
And so, and excess deaths have leveled out.
And they're lower.
The peak was in 21.
Overall, U.S. last year was about 3%.
The young still continue to die excessively.
But overall, excess deaths have come down.
What we need to watch is real-time data like disabilities.
And if I see another spike like I did last June, we can expect another wave coming because morbidity leads mortality.
So right now, it seems like we're in a lull.
But the cancer trends are disturbing.
And cancer spending, if it's a leading indicator, is up 14% since 2020.
And the long-term growth rate was 1.7%. is up 14% since 2020.
And the long-term growth rate was 1.7%. Now it's 6.9%.
So cancer has become a growth industry, unfortunately.
We see Pfizer gobbling up a cancer company,
going on the Super Bowl ads,
talking about their pivot to cancer.
And the premium they paid for this company is outrageous. Other
companies are now scrambling to buy cancer companies. So cancer is a growth industry.
So I don't want to get too far ahead of ourselves and be gloom and doomers, but I'd like to say it's
leveling off, but we don't know yet. And I want to talk about the next study, which is even more
interesting and has some puzzling results, but is it also more clear? And I want to talk about
some absolute numbers as well. And before we do that, I just want to pick up on what you and I
talked offline about this, this idea of cancer as an industry. It's huge. And I remarked the same
thing. Isn't it funny that Pfizer and Moderna are both hawking their new mRNA technology as a way to
treat cancer moving forward? Nothing like creating a disease process and then coming up with the cure.
And so I think what you're reporting right now with regard to increase in cancer spending
on treatment technologies, it's sort of dark to think about, but I think it is an
indicator of what's to come. I can tell you clinically what I see and when I talk with
other clinicians, what we are seeing, to put some color on it, is really worrisome cancers in groups
of people in whom they are normally not seen. And what I mean by that is
aggressive lung cancers in people in their 30s and 40s, non-smokers, aggressive colon cancers
in people in their early 40s, resurgence of cancers that had been deemed to be in remission,
sometimes for 10 or more years, and very, very aggressive tumors that are resistant
to the normal chemotherapy regimens where people are going from diagnosis of a tumor,
whether it's in the colon or the lung or the breast, that's the size of a pea that all
of a sudden is the size of a walnut overnight.
These tumors seem to be on steroids. They've been called turbo cancers,
but we are seeing a lot of it. And what you are showing is just the gross numbers on it.
But I could say when you compare your data to what we're seeing clinically, I think they coincide.
And unfortunately, the iceberg on that piece. So let's get into the next piece you want to talk about.
And then we'll take a break and come back and finish it.
Yeah, sure.
So we dropped a second report on ResearchGate.
Carlos Allegra, Yuri Nunes are the authors.
And David Weissman, I think, got an acknowledgement.
He was busy and didn't co-author this paper. But we studied all age groups with a specific analysis of 75 to 64.
And we found something interesting.
Chart number three, Caleb, is showing that it's a little more clean in this chart.
There was no signal in 2020 and a clear deviation from trend in 21 and
22. The numbers are the following. So underlying cause is, I'm reading numbers here, was basically
minus 0.1% in 2020 for this age group. Z-score basically zero. 4.8% increase in 21, a 10 Z score and 11.5% increase in 2022, a 24 Z score.
So clear signal and more demarcation in this age group in 2021.
So, you know, obviously for this age group, you have to investigate what happened after 2020 specifically and began in 2021. The absolute numbers we looked at, I don't have charts for
this, but we looked at underlying cause and multiple cause. In multiple cause, there was a
signal in 2020, which made sense because COVID took out a lot of cancer patients that were already,
you know, comorbidities. So that signal, we saw a 3.4%
increase in multiple cause in this age group, which is a 12 standard deviation. So it was a signal.
And what should have happened, because we pulled forward, there should have been in this age group,
because they're all the pull forward effect of these cancer patients, and we should have seen
multiple cause cancer the next year go down, negative excess
multiple-cause cancer. We saw it actually accelerate to 9.2% in 21, a 34, I don't even
want to get into the Z score, it's off the charts, and then a 16.4% increase in 2022.
So there should have been, in multiple-cause, there should have been a pull-forward effect,
meaning the bucket next year should have been filled up less and would have been harder to fill the bucket.
But not only did we fill the bucket, we filled it more.
So this is a problem.
And you know what I'm talking about, Dr. Kelly, that there should have been a pull-forward effect, and there wasn't.
So underlying cause was a clear signal, multiple cause.
We should have seen negative excess deaths, but we didn't.
We saw add-ons and add-ons.
And the absolute numbers are kind of stunning.
For underlying cause in 2022, the excess cancer deaths were about 18,000.
For multiple cause excess cancer deaths with another contributing factor were 29,000.
So about 40,000 excess underlying multiple
cause deaths in 2022. That's a lot of people in this age group. The other thing is,
it's just occurring to me, and I don't know if you have an answer to this at all, but
one of the things I said very early in the pandemic, and I stand by it today, is that the virus is real. The statistics are not. Given the propensity they had to over classify things as COVID deaths, I wonder how many deaths were classified as COVID deaths that actually ultimately were deaths from cancer or one of these other things. You know, hospitals had a gross financial incentive to classify something as a COVID
death.
So I suspect if the numbers you're seeing, I think are probably an underestimation of
the actual deaths from cancer or some of these other causes, because I suspect that there
were many things that were written down as or codified as a COVID death that actually
were deaths from a different cause
likely related to the vaccines. I don't know if you have any insight on that, but that's just my
gut feeling. That's a definite possibility. We're working with the codes they gave us,
and that's why we looked at both underlying cause and multiple cause, knowing that in 2020, we'd see cancers.
We should see cancers up in 2020 because comorbidities took some people out.
Absolutely.
One other thing I want to point out, which is I've got to point it out because we report the data.
So across all age groups except one, there was a rise in cancers.
Anything under age 15 in this study, the sample size is smaller.
The signals aren't as clear.
We got a brown signal in 22, but it should be ignored.
But between 15 and 54, we saw increasing cancers into 21 and 22.
And specifically, the hardest hit group was 15 to 24. But in ages 55
through 64, there was negative excess cancer deaths in 21 and 22. That needs to be investigated.
That's interesting to us. And we have to acknowledge that that's an age group that
doesn't seem to be affected. So we have a theory.
We're not going to talk about the theory until we do more work, but it'll be interesting
if we can prove what we think.
Well, I'll tell you, we were going to cut to an ad break, but when looking at your two
charts that you're showing with this increase from 21, 22, 23, God forbid, if the next dot on
your chart continues to go up, we are in a world of hurt. There's going to be a tsunami, not only
of illness and suffering, but also cost associated with this increased rise in cancers. I'm really hopeful that it's going to start to
plateau, but I've got my doubts. So let's cut to an end break and then we'll come back.
Yeah. Go ahead. Go ahead. Finish your thought. I do. I do. I do as well. I want to, I'm not
cheering on accelerating trends. We do seem to be after the 2023 in a lull. Let's see what 2024 brings
and watch the disability data. That's early indicator.
Yep. Okay. We'll come back after the break and get into the disability info.
You can spend thousands of dollars and dozens of hours trying to look a few years younger,
or you can skip all that and the hassle and go with what works genucell skincare genucell is the secret to better skin
their products are made in the usa using a proprietary technology that combines a naturally
effective base with non-gmo ingredients in fact you might have witnessed the astonishing effects
of genucell during a recent unplanned moment of our show when just a little genucell xv
restored my skin within minutes right
before your eyes. That is how fast these products work. I know I'm a snob about the products I use
on my face. Everybody knows it. Every time I go to the dermatologist's office, they're just rows
and rows of different creams. Retinols, vitamin C cream, under eye cream, night creams. And then
when I get to the counter, they're overpriced.
All kinds of products that you can all find at GenuCell.com.
Susan and I love GenuCell so much, we've created our own bundle so you can try our
favorite anti-wrinkle creams, correcting serums, under eye treatments.
Say goodbye to those fine lines, forehead wrinkles, skin redness, even those dark under
eye bags.
Women and men of all skin types, Genucel has got you covered. Order right now at genucel.com
slash drew to save 50%, actually over 50%, and you'll get a free luxury spa box plus free shipping.
That is genucel.com slash drew, G-E-N-U-C-E-L.com slash D-R-E-W. We all know the value of a good
night's sleep. We feel better, look better, have more energy to spare, but you
could be missing out on all of those benefits if you're sleeping on sheets that are too hot or too
cold or just plain uncomfortable. I have the solution. Cozy Earth Bedding. Cozy Earth is the
softest and most comfortable sheets, blankets, loungewear, and more. They use premium viscose
from highly sustainable bamboo and we sleep in them regularly. I wear their t-shirts. Susan wears
their pajamas.
Cozy Earth Bedding comes with a 100-night sleep trial,
which means you have up to 100 nights to sleep on them,
wash them, try them out.
If you're not in love,
just return them within 100 days for a full refund.
Susan and I love them.
In fact, we have Cozy Earth sheets on our bed right now,
and they made a huge difference in our sleep.
If you've never tried Cozy Earth, we have some awesome news.
You can save up to 35% off Cozy Earth right now.
But hurry, this offer will not last.
Go to CozyEarth.com, enter my promo code Drew at checkout for up to 35% off on your first order.
That is CozyEarth.com, promo code Drew, C-O-Z-Y-E-A-R-T-H, CozyEarth.com, code D-R-E-W.
You asked for it and the wellness company has delivered.
The medical emergency kit replete with ivermectin, prescription antibiotics,
and more continues to fly off the shelves.
We keep one here at home.
And there are three new kits you need to know about and more are coming.
The contagion emergency kit was inspired by the high demand for the medical kits.
In that contagion kit, you'll find ivermectin, hydroxychloroquine, antibiotics, budesonide, and a nebulizer.
And a must for your next trip is the Travel Emergency Kit,
something I made sure exactly what I give my patients is in this kit and some more.
The kit includes remedies for jet lag, a variety of infections, even GI ailments.
Imagine your flight getting grounded anywhere,
say even in the U.S., and you start getting sick. You do not want to be at the mercy
of the U.S. healthcare system or any healthcare system. At home, we keep the Ultimate First Aid
Kit on hand. It has over 20 essential supplies and medications for situations when time is of
the essence. Order one for your car and your go bag. Because these kits contain prescriptions,
your purchase includes a telemedicine consultation as well as an instruction manual. Go to
drdrew.com slash TWC for 10% off. That is drdrew.com slash TWC for 10% off all your orders.
I'm very excited about these kits. Go to drdrew.com slash TWC. There's nothing in medicine that doesn't boil down to a risk-benefit calculation.
It is the mandate, public health, to consider the impact of any particular mitigation scheme on the entire population.
This is uncharted territory, Drew.
Welcome back.
Again, Dr. Kelly Victory filling in for Dr. Drew, who's traveling today. I'm joined
today by Ed Dowd, who's presenting some great information, as he always does, with regard to
trends in diseases, death rates, disability since the pandemic began, and more specifically,
since the rollout of the vaccines.
And while Ed does not really pontificate about what's causing all of this, it's the vaccines.
You heard it here. It's the vaccines. We all know it. This is not long COVID. This is not the result of COVID, the virus. It's the result of this wildly failed, dangerous mRNA
shot that was launched, foisted on the public. It wasn't even launched. It was foisted upon
an unwitting public who was mandated, shamed, coerced, or worse into taking these shots,
many of them against their better judgment and their will. So I appreciate you
being here, Ed. Let's pick up where we stopped with regard to you were showing some data. I
think we're going to get into the disability data next that you're presenting. Yeah. So this is a
follow-on report from our UK PIP disability data we put out. We drilled down into neurological
diseases and deaths. This is disabilities, not deaths. And in this chart, we're just showing
these are new claims above, you know, trend. And you can see that they really, really didn't really in 2020 then took off uh they were up uh 15 up 15.6 percent in 21 and then up 95 percent and uh
that's absolute numbers and if you go to the next chart it'll show the percentage changes
you can see the absolute number is about 15 000 uh in 2022 above trend uh trend so that that's
the increase above trend these are new claims neurological, neurological claims, all neurological. So
there's the, we look at the system and then there's specific causes. This is the whole
neurological system. These are new claims. That's an amazing number. And, you know,
it's clear to us. And when we analyze it down into the monthly data, it really started taking
off in June of 2021, coincidentally with a lag to a
novel therapeutic that came out. So there's a temporal relationship really started taking off
when you look at the monthly data in June of 2021. And these numbers are not small. Again,
for this age group, they're 15,000. In the tweet I put out, I took from the all age group, a different report, 30,000. So I've
corrected it below, but 15,000 people in this age group in the UK are claiming new neurological
disabilities. And this is a treasure trove of data for us because it's a public disability
system that gets down into causes. In the U.S., we don't have that.
So we just look at all disabilities in total without drill down.
Yeah, that's what I was going to ask.
Hang on for a second.
That's what I was going to ask, Ed.
So this is from the U.K., and it's because you're able to parse out the data,
or they parse out the disability data differently than we do here in the United States,
where it's all glommed together in one big bucket versus by disease process. Correct?
Yep. Correct. And what's interesting is we also looked at excess deaths in the neurological space.
The problem, again, is the same problem, the reporting problem we have in 2022,
in that there's a 30% gap.
We're still waiting for the results to come in.
So we use adjusted numbers.
But what do we know about 2023?
Total all-cause mortality for this age group, 15 to 44, it was up over 2021 to a new high.
So we think these numbers, when they come in, will be very close to what we adjust.
And the numbers are as follows. That's why you have to take what we what we adjust and then the numbers are
that's why you have to take them with a grain of salt the numbers are as follows um the increase
was uh 18 percent in 2021 and 32 percent in 2022 with a z score of six in uh 21 and 10 and 22. so
there's signals uh of excess neurological deaths again taken with a grain of salt because we had to
use adjustments. But again, given what we saw in all-cause mortality in 2023 in this age group
went to a new high, we suspect when all the numbers come in and the historical figures,
we're probably dead spot on with our measurement. And although this is specific to neurologic disabilities in the UK,
you had reported, as I recall, Ed, significant increases in the disability claims in the United
States all in for all disabilities earlier on in the vaccine rollout. Isn't that correct? You had, it seems to me that you reported.
Yeah, the disabilities in the U.S.
took off in February of 21.
And the rate of change recorded that year
was four standard deviations,
meaning it was bumping along,
nothing going on.
Then it took off.
When we measured the rate of change,
it was four standard deviations from its history,
which means that's just mathematical speak for trend change signal. And it took off and
to the naked eye, anybody can look at this. This isn't rocket science. You can see civilian labor
force disabilities going like this with some noise. And then around 2021, it just went like this,
straight up. And then it paused for a little bit, hit a high in September of 22, paused into June of 23, then took off again.
So what we're watching, and this is monthly data, it's survey data.
So it gives you a kind of a, you know, not granular, but it's a good estimate.
So you can figure out the trend.
And if we see another spike, that means deaths are
coming in the future because morbidity leads to mortality. And I'm hoping it goes down and
breaks trend. But right now, it's consolidating like it did last year. Ed, have you and your team
put any financial numbers to what this means, likely, whether it's in the U.S. or in the U.K. in terms of, you know, when you start talking about this wild excess and disability claims, for example, and people dropping out of the workforce, the life insurance claims, all of this.
Have you gotten your arms around it, the economic impact of what this what this will mean for the United States? Yeah, we did an analysis in 22.
We updated it for Senator Ron Johnson recently.
The numbers escape me at the moment,
but I remember the total number,
I believe, between deaths, disabilities, and injuries,
we estimated about $217 billion is the cost,
with $40 billion being the cost, I think, in 2020. So whatever the policy
measurements were, the medicine was worse than the disease. So it's, you know, look, you know,
we're just trying to like score the policymakers and they failed. Excess deaths were 1.1 million
in 21, 22, and 23, as opposed to half a million in 2020.
Disabilities were not present in 2020. They took excess disabilities, they took off in 2021.
And then lost work time did occur in 2020, but it really started taking off in 21 and 22.
So this is, and then again, that figure 217217 billion, thereabouts, doesn't take into account the multiplier effects, loss productivity, because that's just the raw numbers that we calculated from the wages and gross national income accounts.
So it's an estimate.
It could be a factor of two to ten times bigger than that when you factor in loss productivity and multiplier effects.
But it's an expensive proposition.
You brought up something interesting about the CDC earlier. I want to make an analogy. So the CDC
implemented policies, then they measure themselves to see how they did against those policies.
That seems to be a problem inherent in itself. Imagine I implement a portfolio strategy at
BlackRock. I pick 80 growth stocks.
And then over three years later, I tell my clients, I'm not going to tell you how I did.
Sorry.
That's why we have third party people measuring performance every day.
I'm measured every day by outside people who price my fund every day.
Apparently, the CDC has no such mechanism. So they measure their own results of their own policies.
So that's why we don't get any information from them.
And it's really unconscionable.
I was going to talk about that, you know, the quote policymakers and where they have
been or where they haven't been.
You know, the CDC, hopefully people know the CDC just released a 148-page study with regard to the
incidence of myocarditis following the vaccines, and they redacted every single bit of every
single page.
148 pages of fully redacted study.
I mean, that's unconscionable.
How they get away with that is beyond me.
Have you gotten, you know, you certainly have been talking
with people like Senator Ron Johnson, you've been front and center in Washington on multiple times,
you've been getting your data out there. Have you had any feedback from anybody at the CDC or FDA
who's approached you in any way interested in your data or interested in your analysis?
That would be no.
Unbelievable. I mean, you got to think about that. Let that sink in. I would say that there
is a group, they are the organization, the CDC specifically, Center for Disease Control and Disease Prevention. That's their job, yet they
are not interested in these exponential increases in different disease processes. I mean, truly,
what the heck is it that they do? Not only have they not evaluated all the VAERS reports,
they've essentially looked into none of them. They're just ready to blow them
off. But you have data that is, and you aren't even saying what is a result of. You're saying,
here's the data. You tell us what's causing this trend. And they aren't even interested in looking
at it. How that's allowed to happen in this country is beyond me. But have you reached out
specifically to them over these past two and a half years?
I wouldn't even know who to begin to reach out to. And it's not my, it's, you know, look,
there's, there's senators, Ron Johnson's asked for information. He's been, you know,
like if Ron Johnson can't, can't get information, there's no information I'm going to get from him.
So we're using the publicly available data that we can.
And, you know, something I want to bring up that's interesting.
So there's been censorship and a cover-up by our regulators.
This creates asymmetric information.
There's a media censorship going on.
There's a collaboration between the media, the government, to suppress this information.
It creates an opportunity.
The opportunity is this data that we now present historically for free. between the media, the government, to suppress this information. It creates an opportunity.
The opportunity is this data that we now present historically for free.
Now people are going to be faced with questions, wondering why things are going on.
This is going to turn into a business.
We didn't even think it was going to be a business, but we've been approached by someone who wants us to make a business proposal.
People that think this kind of information is valuable to decision makers who have no idea
what's going on we're three years ahead of all the academics so this is we didn't think it'd
be a business but it might be a business unbelievable well before we've got a few
minutes the business this should not be a business this should not be a business
right it shouldn't be but it is and it is. And God bless you for actually being
the person or your group being willing to continue. You've been indefatigable during this
process. It hasn't been fun. Like me, you certainly have suffered the slings and arrows.
Everybody's always taken pot shots. When you've done almost everything you've done has been for free,
not as a business. You've really been working to expose this information and make it available to
the government and to the population at a significant personal toll, I might add.
So I appreciate all the work you've done. We haven't raised any money yet, but literally
an individual came to us
and said, write a proposal.
Keep doing what you're doing on the publicly
facing data, but people want
to know what to do going forward. People will
pay for that. That's called projections.
We've had them. We don't put them
out there because we don't want to
scare people and we don't want
people to say you were wrong.
We'll sell it, gladly, but no point in putting it out there.
No, I understand. In the few minutes we have left, I want to touch on this preprint study
that's looking at sort of the sequelae or the side effects, what people have been calling
long COVID. Researchers have been looking at how
long the spike proteins last in the bloodstream, last in different tissues. Now we know that they
stick around. I'm talking specifically the spike proteins from the vaccines last in excess of 280
days. And that's as long as they've really been studied. So we're coming up
that they last as long as a year. We were told people might recall that the mRNA is going to be
eliminated from your body very quickly. The CDC's website still says it gets out of your body within
a matter of days. We know that's a lie. They knew that was a lie at the time that they posted that.
They knew that it made its way into every single major organ system within a matter of hours, 11% of it alarmingly concentrating
in the ovaries and testes. And we certainly are seeing some significant fertility issues.
That's another set of data I'm hoping you guys will ultimately crunch. Do you have, you had a chance to look at
this issue about long COVID versus vaccine injury? No, we haven't, I haven't looked at that paper yet.
Look, this is going to be interesting. This will be the debate and we're going to follow the data
and we suspect, we're not doctors, but there's a spike protein that was in the original
virus in 2020. And there's a spike protein in the vaccine. There could be a chance that some of the
things we're seeing on a very small scale occurred in 2020, but are amplified by the thing that
produces it ad infinitum. So we don't know yet. We're going to have to look into it. But what I
can say
definitively is when they say everything we're seeing is long COVID, that's nonsense.
Yeah. Well, and there's no question. I mean, from a medical perspective, there are many
viruses that can cause a prolonged viral syndrome, what we used to call back in the day,
viral syndrome, post-viral syndrome. Epstein-Barr virus, for example, is well known
for it. Even influenza can cause some months of fatigue and respiratory issues in certain people.
It's uncommon, but it happens and lots of viruses can do it. One of the interesting things is that
it's very easy to tell on tissue staining. You can differentiate between the spikes,
proteins that are caused by the virus versus spikes that are caused by the bag that are the produced as a result of the mRNA.
They stain differently.
They have a different nucleocapsid.
You can differentiate.
Dr. Peter McCullough and other people have made it very clear that on autopsies, there's no question that
the myocarditis, for example, has been caused by the vaccines. The spike proteins that they're
finding in the tissue are spike proteins that happen from the vaccine, not from the virus itself.
So I agree with you. I think all of these quote long COVID cases are likely long vaccine cases instead.
What's next on your, just give us a glimpse, Ed.
I know we'll have you back soon because you always have great new data sets, but what's
the next data that you're looking at or capturing and crunching?
Well, we just dropped a bunch of information. Probably we're looking now at
the over-reporting on COVID, see if we can glean what was going on there and come at it,
see if we can make any statements about the over-reporting. And if we can find something
that shows a definitive answer, we'll publish it great well in the meantime I'm gonna let you
go you get if you haven't read Ed's book cause unknown it's really worth looking at so when I
first started to get an idea of what the data sets showed and you take a very interesting look at it
again not from a specifically medical perspective but, just looking at the raw data and following the trends. And I think it's a great
way for people to look at it in a more objective way. If you don't want to buy into the quote,
that it's the vaccine, just look at the raw data and see where it leads you.
And I hope you'll come back soon. Again, sorry for the technology glitches at the beginning. You're always so
accommodating. We appreciate it and really look forward to having you back for the next data
reveal. Thank you. I don't want to interrupt you. I also want to let people know that it looks like
there's an updated edition of Cause Unknown that just recently came out.
That's also available.
It looks like it includes data from 2023.
Is that correct, Ed?
It's not data so much as more news articles.
It's just people mysteriously dying without any commentaries to have it.
We just print the articles.
Good, good.
Awesome. All right. Thanks a bunch, Ed. Appreciate it. And folks, I will give you the quick rundown on the upcoming shows. I
don't know if you've got them printed up there. Vivek Ramaswamy coming on the 9th, and then I'll
be back next Wednesday, the 10th, again, to cover for Drew in his absence. I've got
Ivor Cummins, Fat Emperor. It's always a great conversation. Look at me. You've got Jack Posby,
Matthias Desmet, okay, on the 16th. That should be a great conversation. I think we're still in
a mass formation psychosis, so it isn't over yet, folks. And then everybody's favorite salty
cracker. So thanks very much for tolerating the brief delay COVID. Caleb, you are the best at
sorting it out. Thank you for doing that. Quite hectic over here is literally we go live,
everything crashes. So I rebooted three times, then it worked. So at least we got on.
Thank you guys for sticking with us, especially you, Kelly. You're like a rock star. You just
made it happen. No worries. Thanks for having me. And I will look forward to seeing everybody
next Wednesday when I'm back with Ivor Cummins. Thanks a bunch.
Ask Dr. Drew is produced by Caleb Nation and Susan Pinsky.
As a reminder, the discussions here are not a substitute for medical care, diagnosis,
or treatment.
This show is intended for educational and informational purposes only.
I am a licensed physician, but I am not a replacement for your personal doctor, and
I am not practicing medicine here.
Always remember that our understanding of medicine and science is constantly evolving.
Though my opinion is based on the information that is available to me today,
some of the contents of this show could be outdated in the future.
Be sure to check with trusted resources in case any of the information has been updated since this was published.
If you or someone you know is in immediate danger, don't call me.
Call 911. If you're feeling hopeless or suicidal, call the National Suicide Prevention Lifeline
at 800-273-8255.
You can find more of my recommended organizations
and helpful resources at drdrew.com slash help.